How to Value a Stock: 3 Methods Every Investor Should Know

Learning how to value a stock is the single most important skill you can develop as an investor. Yet most retail investors skip this step entirely. They buy stocks based on price momentum, social media tips, or a vague feeling that "this company is great." The result? They overpay for hyped stocks and miss genuine bargains hiding in plain sight. Valuation is the bridge between speculation and real investing — and in this guide, we'll walk you through the three methods that professional analysts use every day.

Why Stock Valuation Matters

Benjamin Graham, the father of value investing, described the stock market as "Mr. Market" — an emotional business partner who shows up every day offering to buy or sell shares at a different price. Some days Mr. Market is euphoric and quotes absurdly high prices. Other days he's depressed and practically gives stocks away. The key insight: price is what you pay, but value is what you get.

Even the best company in the world can be a terrible investment if you overpay for it. Consider this: if you bought Microsoft at its peak in 2000, it took you 15 years to break even — not because Microsoft was a bad company, but because the price was disconnected from the underlying value. The business kept growing, but you had paid for decades of growth upfront.

Valuation gives you an anchor. When markets panic, it tells you whether to buy more or stay away. When markets rally, it tells you whether you're still getting a reasonable deal. Without valuation, you're reacting to price movements. With valuation, you're making informed decisions.

As Warren Buffett puts it: "If you don't know what a stock is worth, you're gambling, not investing." Let's fix that.

Method 1: The PEG Ratio — Valuing Growth

The PEG ratio is the simplest and most intuitive valuation tool for growth stocks. It answers a fundamental question: how much am I paying for each unit of growth?

The formula is straightforward:

PEG Ratio = (P/E Ratio) / (Annual EPS Growth Rate)

The P/E ratio alone tells you how much you're paying per dollar of earnings. But a stock with a P/E of 30 could be cheap or expensive depending on how fast earnings are growing. The PEG ratio normalizes for growth, letting you compare apples to apples.

How to Interpret the PEG Ratio

• PEG below 1.0 — Potentially undervalued. The stock's growth rate exceeds its P/E multiple, suggesting you're paying less than the growth warrants.
• PEG between 1.0 and 2.0 — Fairly valued to slightly expensive. This is where most quality growth stocks trade.
• PEG above 2.0 — Potentially overvalued. You're paying a premium that growth alone may not justify.

A Practical Example

Let's say Alphabet (GOOGL) trades at a P/E ratio of 25 and analysts expect 20% annual earnings growth. The PEG ratio would be 25 / 20 = 1.25. That suggests you're paying a reasonable price for GOOGL's growth — not a screaming bargain, but not overpriced either.

Now compare that to a company trading at a P/E of 50 with only 15% growth. Its PEG is 50 / 15 = 3.33 — meaning you're paying more than three times the growth rate. That's a red flag.

When to Use It

The PEG ratio works best for growth stocks and compounders — companies with positive and reasonably predictable earnings growth. It's the go-to metric when you're comparing tech stocks, SaaS companies, or any business where growth is the primary driver of value.

Limitations

The PEG ratio has real blind spots. It relies entirely on growth estimates, which are often wrong. It doesn't work at all for companies with negative earnings. And it ignores important factors like debt, cash flow quality, and competitive moats. Think of PEG as a useful first filter, not the final word.

We dive deeper into this in our complete PEG ratio guide.

Method 2: Discounted Cash Flow (DCF) — Valuing Cash

The DCF model is the gold standard of fundamental analysis. Its core idea is elegant: a stock is worth the sum of all future cash flows it will generate, discounted back to today's dollars. A dollar five years from now is worth less than a dollar today, and the DCF model accounts for this through the discount rate.

The 5 Key Inputs

1. Current Free Cash Flow (FCF) — How much cash the business generates after all expenses and capital investments. This is your starting point.
2. Growth Rate — How fast you expect FCF to grow over the projection period. Use conservative estimates; optimism kills DCF accuracy.
3. Discount Rate (WACC) — The weighted average cost of capital, typically 8-12% for most companies. This reflects the time value of money and the risk of the investment.
4. Terminal Growth Rate — The long-term sustainable growth rate after the projection period ends, usually 2-3% (roughly matching GDP growth).
5. Projection Period — How many years you project forward, typically 5-10 years. Longer projections introduce more uncertainty.

A Simplified Walkthrough

Let's value Apple (AAPL) with a simplified DCF. Suppose Apple generates $110 billion in free cash flow. We project 8% annual growth for 5 years, use a 10% discount rate, and assume 2.5% terminal growth.

Year 1 FCF: $118.8B. Year 2: $128.3B. Year 3: $138.6B. Year 4: $149.6B. Year 5: $161.6B. After discounting each year's cash flow to the present and adding a terminal value for all cash flows beyond year 5, you arrive at a total enterprise value. Divide by shares outstanding, and you get an estimated fair value per share.

The actual math involves a terminal value formula (Year 5 FCF x (1 + terminal growth) / (discount rate - terminal growth)), and subtracting net debt. The details matter, but the concept is what's important: you are estimating what the entire future cash flow stream is worth today.

When to Use It

DCF works best for established companies with predictable cash flows — blue chips, consumer staples, industrial leaders. Companies like Apple, Johnson & Johnson, and Procter & Gamble are ideal DCF candidates because their cash flows are relatively stable and predictable.

Limitations

The DCF model is powerful but dangerous in the wrong hands. It's extremely sensitive to assumptions — change the growth rate by 2% or the discount rate by 1%, and the fair value can swing by 30% or more. This is the "garbage in, garbage out" problem. The model is only as good as your inputs, and even small errors compound over a 10-year projection.

The model also struggles with early-stage companies that have no free cash flow yet, cyclical businesses with volatile earnings, and financial companies where cash flow accounting differs from industrials.

For a full walkthrough, see our DCF valuation for beginners guide.

Method 3: EV/EBITDA — Valuing the Business

While P/E is the most popular valuation multiple, professionals often prefer EV/EBITDA. The reason is simple: EV/EBITDA strips out the effects of capital structure, giving you a cleaner view of what the underlying business is worth.

The Formula

EV/EBITDA = Enterprise Value / EBITDA

Enterprise Value (EV) equals the market capitalization plus total debt minus cash. It represents what you'd pay to acquire the entire business. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) represents the operating profit before financing and accounting decisions.

Because EV accounts for debt and EBITDA ignores interest costs, this multiple lets you fairly compare companies with very different capital structures. A company loaded with debt and a company with zero debt can be compared on an equal footing — something P/E cannot do.

What's a "Good" EV/EBITDA?

There's no universal answer — it depends entirely on the sector:

• Technology — 15x to 25x (higher growth justifies higher multiples)
• Healthcare — 12x to 20x
• Industrials — 10x to 15x
• Utilities — 8x to 12x (stable but slow growth)
• Energy — 5x to 10x (cyclical, capital intensive)

The key is to compare a stock's EV/EBITDA against its sector peers and its own historical range. A tech stock at 12x might be cheap, while a utility at 12x might be expensive.

A Practical Example

Consider Johnson & Johnson (JNJ) trading at an EV/EBITDA of 14x. The healthcare sector median is around 16x. JNJ's own 5-year average is 15x. At 14x, JNJ appears to be trading at a slight discount to both its peers and its own history — a potential sign of undervaluation worth investigating further.

When to Use It

EV/EBITDA is the preferred tool for comparing companies within a sector and for M&A analysis. Investment bankers use it constantly because it answers the practical question: "What would I pay for this entire business relative to its operating earnings?"

Limitations

EV/EBITDA ignores capital expenditures, which can be massive for asset-heavy businesses. A company might look cheap on EV/EBITDA but require enormous reinvestment to maintain operations. It also fails for companies with negative EBITDA (early-stage, turnarounds) and doesn't account for differences in tax rates or working capital needs.

How to Blend Multiple Valuation Methods

Here's the uncomfortable truth: no single valuation method is reliable on its own. Each method captures a different angle of a company's value, and each has blind spots. The PEG ratio ignores balance sheet strength. DCF is hostage to growth assumptions. EV/EBITDA ignores reinvestment needs. The real power comes from combining them.

Professional analysts use a weighted blend, adjusting the weights based on the type of stock:

• Growth stocks — PEG gets the highest weight (e.g., 50% PEG, 25% DCF, 25% EV/EBITDA). Growth is the dominant value driver, so the growth-sensitive method leads.
• Blue chips and value stocks — DCF and EV/EBITDA split the weight (e.g., 20% PEG, 40% DCF, 40% EV/EBITDA). For mature businesses, cash flow predictability and relative value matter more than growth.
• Compounders — A balanced blend (e.g., 33% each). These stocks combine growth with stability, so all three perspectives are equally relevant.

At Convex, this is exactly how our conviction engine works. The system classifies each stock first — compounder, growth, blue chip, cyclical, financial — and then applies a custom weighting to the three valuation methods. The result is a single fair value estimate that reflects the stock's specific characteristics.

The concept of triangulation is key. When all three methods converge on a similar fair value, your conviction should be high. When they diverge wildly, it's a signal to dig deeper — one of your assumptions may be wrong, or the stock may defy simple categorization.

See how we apply this in our fair value estimation guide.

Common Valuation Mistakes to Avoid

Even experienced investors fall into valuation traps. Here are the most common ones:

• Using only one method — Each method has blind spots. Relying on P/E alone, for example, would make capital-intensive companies look artificially expensive. Always cross-reference with at least two methods.
• Trusting analyst growth estimates blindly — Wall Street consensus estimates are frequently wrong, especially more than one year out. Build your own scenarios and stress-test them.
• Ignoring the margin of safety — Even the best valuation is an estimate, not a fact. You need a buffer between your estimated fair value and the price you're willing to pay. We explore this concept in depth in our guide on why margin of safety matters.
• Comparing multiples across different sectors — A P/E of 25 means something very different for a tech company versus a utility. Always compare within the same sector and against historical averages.
• Anchoring to a stock's historical price — "It used to trade at $200, so $150 must be cheap." This is a cognitive bias. A stock's previous price says nothing about its current value. Always anchor to fundamentals, not to price history.

Frequently Asked Questions

What is the best method to value a stock?

There is no single best method. The PEG ratio excels at evaluating growth stocks, DCF is ideal for cash-flow-rich businesses with predictable earnings, and EV/EBITDA is the strongest tool for cross-company comparison within a sector. The best approach is to blend all three methods and weight them based on the type of company you're analyzing. When multiple methods agree on a valuation, your confidence in that estimate should increase.

How do you know if a stock is undervalued?

A stock is potentially undervalued when its current market price is significantly below your estimated fair value — and crucially, when that estimate is confirmed across multiple valuation methods. Simply having a low P/E ratio doesn't mean a stock is undervalued; it might just have poor growth prospects. The key is to establish a fair value range using PEG, DCF, and EV/EBITDA, and then look for a sufficient margin of safety between that range and the current price.

Can you value a stock without financial expertise?

Yes, absolutely. While understanding the underlying concepts helps you interpret results and avoid mistakes, you don't need to build spreadsheets from scratch. Tools like Convex automate all three valuation calculations — PEG, DCF, and EV/EBITDA — and present the results in plain language. The key is understanding what the numbers mean, even if you don't calculate them yourself. This guide gives you that foundation.

Start Valuing Stocks Today

You now have the foundational knowledge to value any stock using three proven methods. The PEG ratio helps you gauge whether a growth stock's price is justified. DCF anchors your analysis in real cash flows. And EV/EBITDA gives you a capital-structure-neutral way to compare businesses.

Try running a free conviction analysis on any stock at convex.ltd. Convex automatically calculates fair value using all three methods — PEG, DCF, and EV/EBITDA — and tells you whether the stock is overvalued, fairly valued, or a potential bargain. No spreadsheets required.

This is educational content, not investment advice. Always do your own research before making investment decisions.